712
Participants
Start Date
April 29, 2010
Primary Completion Date
December 1, 2012
Study Completion Date
December 21, 2012
Dutasteride
Basically there is no treatment allocation. Subjects who would be administered of dutasteride at their physicians' discretion will be enrolled. Dosage regimen will be recommended according to the prescribing information. Subjects will be enrolled consecutively.
GSK Investigational Site, Daejeon
Lead Sponsor
GlaxoSmithKline
INDUSTRY